NCT06742710View on ClinicalTrials.gov

Liraglutide Treatment in Obese Infertile PCOS Women

PHASE4RecruitingINTERVENTIONAL
Enrollment

890

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

May 30, 2029

Study Completion Date

December 31, 2029

Conditions
PCOSObesityInfertility
Interventions
DRUG

Liraglutide and metformin

Liraglutide 3.0 mg or maximum tolerable dose/day × 12 weeks and metformin 1500 mg/day until pregnancy.

DRUG

Metformin

Metformin 1500 mg/day until pregnancy

Trial Locations (3)

Unknown

RECRUITING

Peking University Third Hospital, Beijing

NOT_YET_RECRUITING

Beijing Obstetrics and Gynecology Hospital, Beijing

NOT_YET_RECRUITING

Haidian District Maternal and Child Health Care Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER